Actinotetraose Hexatiglate (Tigloside) is primarily utilized in the field of biomedical research for its potential in modulating cellular processes. It has shown promise in studies focusing on immune response regulation, where it may help in understanding and potentially treating autoimmune diseases. Additionally, this compound is explored for its role in enhancing the efficacy of certain drug delivery systems, particularly in targeting specific cells or tissues. Its unique structure allows it to interact with biological membranes, making it a candidate for research in membrane biology and the development of novel therapeutic agents.